# DESCRIPTION

## CROSS REFERENCE

- claim priority benefit

## FIELD OF THE INVENTION

- define markers for NME

## BACKGROUND OF THE INVENTION

- motivate NME research

## BRIEF SUMMARY OF THE INVENTION

- introduce Necrotizing Meningoencephalitis in canines
- describe markers associated with NME risk
- detail combination of markers for identifying NME
- provide method of classifying subject to NME disease risk group
- describe isolated nucleic acid molecule with NME-associated markers
- summarize application of invention to various canine breeds
- define isolated nucleic acid molecule
- describe method of classifying NME disease risk group
- provide examples of marker detection methods
- describe set of molecular probes for assessing NME risk

## DETAILED DESCRIPTION OF THE INVENTION

- introduce necrotizing meningoencephalitis (NME) risk assessment method
- define haplotype and its relation to NME
- explain single nucleotide polymorphisms (SNPs) and their role in haplotype detection
- describe haplotype blocks and their association with NME
- discuss tag SNPs and their use in representing haplotype diversity
- outline methods for detecting haplotype blocks and tag SNPs
- explain use of controls and statistical models in assessing NME risk
- discuss parameters for evaluating marker significance, including likelihood ratio, odds ratio, and hazard ratio
- broaden definition of markers to include various molecular structures and sequences
- describe marker detection methods
- detail direct detection methods
- detail indirect detection methods
- describe sequencing methods
- describe expression assessment methods
- describe ligand-based detection methods
- describe molecular probes for detection
- describe prediction of cellular or physiological characteristics

## EXAMPLES

- present multiple examples of genome-wide association study

### Example 1

- describe study population and methods for SNP genotyping and statistical analysis

### Example 2

- identify disease-associated SNPs genome-wide

### Example 3

- identify disease-associated haplotype blocks over DLA II region on chromosome 12

### Example 4

- identify disease-associated haplotype blocks over STYX region on chromosome 8

### Example 5

- identify disease-associated indels over DLA II region on chromosome 12

### Example 6

- confirm HLA-DPB1 deletion variant association with NME

